Big Tech and pharmaceutical companies are accelerating the implementation of artificial intelligence in the healthcare ...

Merck & Co. Inc. closed 36.37% below its 52-week high of $134.63, which the company reached on June 25th.

Co's stock has reached a 52-week low, dipping to $85.71. This downturn reflects a significant shift from the previous year, with the pharmaceutical giant experiencing a 1-year change of -31.59%.

We recently published an article titled Why These 10 Dividend Stocks Are Declining? In this article, we are going to take a ...

Newmont Co. (TSE:NGT – Get Free Report) has been given a consensus rating of “Moderate Buy” by the nine analysts that are covering the stock, Marketbeat Ratings reports. Five research analysts have ...

Robert F. Kennedy Jr.'s nomination for US health secretary advances with crucial Republican support, despite controversy over ...